Studien | Der Arzneimittelbrief

Action in Diabetes and Vascular disease - preterAx and diamicroN modified release Controlled Evaluation (1)

Literaturstellen

Diabetologia 2001,44,1118; 2009,52,2027; 2328; 2010,53,821; 2320; 2011,54,1608; 2012,55,636; 2013,56,2105; 2014,57,2465; 2016,59,2603; 2018,61,780; 1581; 2019,62,1988; 2020,63,1637
J.Hypertens. 2001,19Suppl.,S21; 2007,25Suppl.1,S23; 2008,26Suppl.2,S11
S21
S23; 2010,28,1141; 2021,39,1689
Diabet.Med. 2005,22,882; 2013,30,918
J.Hum.Hypertens. 2005,19Suppl.1,S27; 2006,24Suppl.3,S19
Blood Press. 2006,15,340
Lancet 2007,370,829
Health Qual.Life Outcomes 2007,5,21
Diabetes Care 2008,31,708; 2009,32,2068; 2009,32Suppl.2,S357; 2009,32,2068; 2011,34,2491; 2012,35,2201; 2014,37,1353; 2359; 2202; 2015,38,1393; 1891; 2016,39,1796; 2270; 2018,41,163; e39; 2020,43,1293; 2021,44,1622; 2025,48,279